Factors Affecting the Price of Yervoyg

Yervoy (ipilimumab), an immune checkpoint inhibitor, has a price influenced by multiple factors. High R&D costs for developing the first CTLA-4 inhibitor and conducting clinical trials for various cancers drive up pricing. 

Factors Affecting the Price of Yervoyg

Its monopolistic market position due to patent protection allows the manufacturer, Bristol Myers Squibb, to set premium rates. Production complexity, including specialized biologic manufacturing and quality control, adds to costs. Market demand for advanced cancer treatments and regional healthcare policies (e.g., insurance coverage) also impact final prices paid by patients.